Feed / MRNA

Moderna, Inc.

MRNA

Healthcare · 145.10 +8.9% today

Partial group confirmationMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

Moderna, Inc.'s move is being confirmed by its market group.

MRNA accounts for 24.4% of the group's measured movement across 7.3 effective names. raw member direction is mixed; 6 of 10 SPY-adjusted paths align to the upside. Capital-flow agreement is 53%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

SPY-adjusted 5m paths
Role in the moveCounter-move#1 of 10 by movement share
Group movement share24.4%Absolute path energy—not portfolio weight
Relative path-6.05%counter
Effective breadth7.3 / 10broad
Relative alignment6/10upside path · 4 counter-moving
Capital-flow agreement53%not yet clean
SEQUENCE READ

NTRA, VCYT, CAI moved materially before MRNA. MRNA crossed its material path threshold at 10:45 ET, 25 minutes after the first measured mover. CRSP, SYRE followed.

EVIDENCE COVERAGE

5 of 10 members in Cancer Diagnostics are active. 0 of 8 disclosed connections are confirming.

What would change this read
  • At least 7 of 10 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as MYGN begins moving with the group.

Invalidation: The live read weakens if participation falls to 3 of 10 members or fewer.

Watch this read

Who this business touches

The relationships behind MRNA

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

MRKMerck & Company, Inc.partnerMay 1, 2026

We are advancing intismeran in collaboration with Merck, with eight Phase 2 and Phase 3 clinical trials underway across multiple tumor types.

IMTXImmatics N.V.partnerFeb 20, 2026

We have also expanded our oncology portfolio with early-stage programs, including mRNA-4106 (a cancer antigen therapy), mRNA-2808 (a T-cell engager), and mRNA-4203 (a cell-therapy enhancer).

Depended on by

PSNL25.0% of PSNLcustomerMay 7, 2026

For example, we are providing genomic testing services to ModernaTX, Inc.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 23 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

MRNA is currently a Participant in the organic co-movement group Cancer Diagnostics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.